Madrigal Pharmaceuticals, Inc. (BIT:1MDGL)

Madrigal Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 20, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,650	6,501	4,133	4,846	1,274	1,406
Market Cap Growth	42.45%	57.29%	-14.71%	280.38%	-9.37%	12.21%
Enterprise Value	8,998	5,651	4,028	4,749	1,012	1,132
PS Ratio	15.29	37.36	-	-	-	-
PB Ratio	18.10	8.92	11.27	26.24	7.39	7.17
P/TBV Ratio	18.31	8.98	11.27	26.24	7.39	7.17
EV/Sales Ratio	14.21	32.48	-	-	-	-
Debt / Equity Ratio	0.55	0.16	0.29	0.25	0.00	0.00
Asset Turnover	0.61	0.21	-	-	-	-
Quick Ratio	3.13	5.79	5.35	3.10	3.52	6.10
Current Ratio	3.44	6.10	5.38	3.12	3.54	6.13
Return on Equity (ROE)	-41.22%	-80.35%	-123.98%	-150.12%	-110.92%	-61.61%
Return on Assets (ROA)	-15.78%	-36.98%	-47.41%	-57.71%	-54.09%	-35.44%
Return on Capital Employed (ROCE)	-31.70%	-57.00%	-72.90%	-119.00%	-123.40%	-86.00%
Earnings Yield	-2.55%	-6.92%	-8.18%	-5.70%	-16.69%	-11.76%
FCF Yield	-1.43%	-6.79%	-7.13%	-4.35%	-12.71%	-9.18%
Buyback Yield / Dilution	-6.98%	-13.83%	-9.05%	-3.64%	-7.05%	-0.34%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.